R. H. McDermott

A phase I study of intravenous bryostatin 1 in patients with advanced cancer

J Prendiville, D. Crowther, Nicholas Thatcher et al. · British Journal of Cancer · 1993 · 145 citations · Full text

Medicine, Oncology, Pharmacology +7

Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: Induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity

Christof Scheid, Rosemary Young, R. H. McDermott et al. · Cancer Immunology Immunotherapy · 1994 · 52 citations · Full text

Life Sciences, Immunology, Clinical Immunology +16

Long-term in vitro correction of alpha-L-iduronidase deficiency (Hurler syndrome) in human bone marrow.

LJ Fairbairn, L. S. Lashford, Elaine Spooncer et al. · Proceedings of the National Academy of Sciences · 1996 · 50 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +14

Uptake of glutamate, not glutamine synthetase, regulates adaptation of mammalian cells to glutamine-free medium

R. H. McDermott, Michael Butler · Journal of Cell Science · 1993 · 47 citations · Full text

Life Sciences, Biochemistry, Cell Biology +12

CL22 – a novel cationic peptide for efficient transfection of mammalian cells

AMR Haines, A Irvine, A. Mountain et al. · Gene Therapy · 2001 · 44 citations

Pharmacy, Biotechnology, Molecular Pharmaceutics +11